Navigation Links
Sequent Medical, Inc. lanza el microcatéter VIA
Date:12/11/2012

ALISO VIEJO, California, 11 de diciembre de 2012 /PRNewswire/ -- Sequent Medical, Inc. ha anunciado hoy la recepción de la Marca CE para el microcatéter VIA™, además de iniciar la introducción comercial de su nueva gama de productos en mercados selectos.

VIA se usará para el suministro y despliegue del sistema de embolización de aneurisma WEB® de Sequent, que se usa para tratar los aneurismas cerebrales. VIA está disponible actualmente en dos modelos, VIA y VIA PLUS.

"El microcatéter VIA proporciona una combinación optima de propiedades para la colocación estable de WEB, retirada y navegación, y permitirá a los médicos tratar una amplia gama de aneurismas a través de WEB", afirmó el doctor y médico Werner Weber, responsable del Departamento de Radiología y Neuroradiología Intervencional de Klinikum Vest, Knappschaftskrankenhaus, Recklinghausen, Alemania.

"En combinación con las adiciones planeadas para nuestra plataforma WEB, VIA demuestra el compromiso en marcha de Sequent Medical para desarrollar una amplia gama de tecnologías innovadoras basadas en catéter para los especialistas neurovasculares y sus pacientes", comentó Tom Wilder, director general y consejero delegado.

Acerca de Sequent Medical, Inc.

Sequent Medical, Inc. (www.sequentmedical.com) es una compañía privada de instrumentos neurovasculares cuyo objetivo es el desarrollo de innovadoras tecnologías neurovasculares basadas en catéter. El sistema de embolización de aneurisma WEB y microcatéter VIA han recibido la Marca CE. No está disponible para su venta o uso en Estados Unidos. Sequent Medical Inc. tiene su sede central en Aliso Viejo, California, además de tener su sede de operaciones europeas en Bonn, Alemania.

Acerca del sistema de embolización de aneurisma WEB

Construido basándose en las bases de los muelles embólicos endovasculares, WEB es un dispositivo de embolización neurovascular intra-sacular de baja porosidad que se ha diseñado para servir como puente entre el cuello de un aneurisma intracraneal de tipo con rotura o sin rotura y promover la inmovilidad rápida de peri-procedimiento. WEB permite a los médicos tratar los aneurismas intracraneales con la familiaridad de una aproximación intra-sacular usando los biomateriales establecidos.


'/>"/>
SOURCE Sequent Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sequent Medical, Inc. Launches VIA Microcatheter
2. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
3. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
4. Barrack, Rodos & Bacine Files Class Action Lawsuit Against St. Jude Medical, Inc.
5. Nonin Medical, Inc. arbeitet bei Pulsoxymetrieangebot für 2net-Plattform für drahtlose Gesundheitslösungen mit Qualcomm Life zusammen
6. Nonin Medical, Inc. Collaborates with Qualcomm Life to Provide Pulse Oximetry for the 2net Platform for Wireless Health Solutions
7. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
8. Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
9. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
10. Boston Scientific to Acquire BridgePoint Medical, Inc.
11. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017  The Global Health Innovative Technology ... formed to battle infectious diseases around the globe, ... that could help deliver a range of new ... This latest round of targeted ... trial testing a pediatric formulation of a drug ...
(Date:3/29/2017)... Calif. , March 29, 2017 ... for patients as the highest standard in quality ... Krypton Vision introduces its objective Wavefront-driven refraction technologies ... subjective approach. This enables an unprecedented level of ... - exceptional vision relegated to Topgun Navy fighter ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global lifestyle drugs market to grow ... The report, Global Lifestyle Drugs Market 2017-2021, has been prepared ... The report covers the market landscape and its growth prospects over ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... ... the main cause of hay fever in the United States, with an estimated 95 percent ... to July each year; with the worst time for sufferers being June and July. ... ) provide an effective defense against grass pollen; they are proven in independent studies to ...
(Date:3/29/2017)... ... ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower program in ... who have participated in the program every summer. The 2017 Serve, Learn, & ... enrollment. Visit http://www.ghana.yfiexperience.org to learn more. , “I have sent my ...
(Date:3/29/2017)... ... ... Sports Brand EXOUS Bodygear announced today a special sale price for the EX-701 ... of March, the price will be only $19.97. The EXOUS Bodygear 65cm exercise ... retail price $19.97). , The special promotional prices are to help individuals get their ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based on research ... challenges employers face in trying to balance both short-term and long-term benefits demands. ... Adding to the growing complexity, companies are finding that the short-term strategies used ...
Breaking Medicine News(10 mins):